Product Information

AUSTEDO XR 36 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $421.0770 per EA under NDC 68546047456. Its NADAC has been published 84 times since Nov 20, 2024.

AUSTEDO XR 36 MG TABLET

deutetrabenazine
$421.0770per EA

Strength

36 mg/1

NDC

68546047456

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

DEUTETRABENAZINE

Approval Type

New Drug (NDA)

FDA Application

NDA216354

On Market Since

5/29/2024

Price Statistics

The NADAC for AUSTEDO XR 36 MG TABLET has been published 84 times since Nov 20, 2024, and over the history we have for it it has risen 8.1%. The table below summarizes its recorded NADAC range and movement.

Current price$421.0770 per EA
All-time high$421.0770 (Jun 24, 2026)
All-time low$389.3786 (Dec 18, 2024)
52-week high$421.0770
52-week low$394.3131
Median price$399.1131
Average price$402.4919
Largest weekly change+5.5% (Jan 7, 2026)
Weeks tracked84
Tracking sinceNov 20, 2024

Price History

1W

0.0%

1M

+0.0%

3M

+1.2%

6M

+6.7%

1Y

+6.2%

3Y

N/A

5Y

N/A

All

+8.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the deutetrabenazine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of AUSTEDO XR 36 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO XR 36 MG TABLET, manufactured by Teva Neuroscience, Inc., is $421.0770 per EA (NDC 68546047456), effective Jun 24, 2026.

How has the price of AUSTEDO XR 36 MG TABLET changed over time?

Over the history we have for it, the NADAC for AUSTEDO XR 36 MG TABLET has risen 8.1%. It has been tracked across 84 weekly CMS publications since Nov 20, 2024.

What are the highest and lowest recorded NADAC prices for AUSTEDO XR 36 MG TABLET?

Since Nov 20, 2024, the NADAC for AUSTEDO XR 36 MG TABLET has ranged from a low of $389.3786 (Dec 18, 2024) to a high of $421.0770 (Jun 24, 2026), with a median of $399.1131 per EA.

Are there cheaper alternatives to AUSTEDO XR 36 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AUSTEDO XR 36 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures AUSTEDO XR 36 MG TABLET?

AUSTEDO XR 36 MG TABLET (NDC 68546047456) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.